北印度幼年特发性炎症性肌病中肌炎特异性与相关性抗体的临床表型谱
该研究回顾性分析北印度113例幼年特发性炎症性肌病(JIIM)患儿,用16抗原免疫印迹法检测肌炎特异性抗体(MSA)和肌炎相关性抗体(MAA)。72.5%患儿抗体阳性,抗NXP2最常见,其次为抗MDA5、抗TIF-1γ和抗Mi2;不同抗体与起病年龄、肌肉无力、钙质沉着、皮肤病变及间质性肺病等表型相关。
要点
- JIIM患儿MSA/MAA阳性率72.5%,抗NXP2最常见。
- 抗NXP2阳性者起病年龄更小,起病时严重肌无力及随访持续钙质沉着更多。
- 抗MDA5-JDM患者关节炎、反向Gottron丘疹、口腔溃疡及ILD发生率更高。
核心结论
- 抗NXP2抗体是该北印度JIIM队列中最常见的MSA。
- 不同MSA/MAA与特定临床表型相关,强调区域特异性数据对理解疾病变异和指导管理的重要性。
研究设计与样本
- 回顾性队列研究,纳入1992至2024年印度昌迪加尔三级转诊中心儿童风湿病门诊的JIIM患儿。
- 173例JIIM患者中113例完成MSA/MAA检测,包括幼年皮肌炎89例、临床无肌病性皮肌炎8例、重叠肌炎13例、幼年多肌炎3例。
- 采用16抗原免疫印迹法(Euroline Autoimmune Inflammatory Myopathies 16 Ag, Euroimmune, Lübeck, Germany)检测MSA/MAA。
主要发现
- 72.5%(82/113)患儿自身抗体阳性,其中MSA 70例、MAA 12例。
- 抗体阳性者中抗NXP2最常见(n=24),其次为抗MDA5(n=14)、抗TIF-1γ(n=12)、抗Mi2(n=9)。
- 抗NXP2阳性者起病年龄更小[3.15岁(1.2-11.88岁),p=0.015],起病时严重肌无力(p=0.04)及随访持续钙质沉着(p=0.004)更多。
- 抗TIF1γ抗体阳性者随访中持续皮肤病变(p<0.001)更多。
- 抗MDA5-JDM患者关节炎(p=0.001)、反向Gottron丘疹(p=0.003)、皮肤溃疡(p=0.065)、口腔溃疡(p=0.012)及ILD(p<0.001)发生率更高。
关键数值与推荐
- MSA/MAA阳性定义为16抗原免疫印迹法检测到相应抗体。
- 抗NXP2阳性与起病年龄小[3.15岁(1.2-11.88岁),p=0.015]、严重肌无力(p=0.04)、持续钙质沉着(p=0.004)相关。
- 抗TIF1γ阳性与持续皮肤病变(p<0.001)相关。
- 抗MDA5阳性与关节炎(p=0.001)、反向Gottron丘疹(p=0.003)、皮肤溃疡(p=0.065)、口腔溃疡(p=0.012)、ILD(p<0.001)相关。
临床怎么用
- 对JIIM患儿应检测MSA/MAA以辅助临床分型和预后判断。
- 抗NXP2阳性者需关注起病时严重肌无力及随访钙质沉着。
- 抗MDA5阳性者应警惕关节炎、皮肤溃疡、口腔溃疡及间质性肺病。
局限性
- 单中心回顾性研究,仅113例完成抗体检测,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Myositis-specific autoantibodies (MSAs) and myositis-associated autoantibodies (MAAs) are increasingly being identified in juvenile inflammatory myositis (JIIM). The current study's objective was to characterize the incidence and clinical-phenotypic profile of MSA/MAA in a cohort of JIIM from North India. METHODS: We reviewed the medical records of the Pediatric Rheumatology Clinic of a tertiary care referral centre in Chandigarh, North India (1992 to 2024) and analysed the clinical details of children with JIIM. MSA/MAAs were assayed using a 16-antigen kit immunoblot assay (Euroline Autoimmune Inflammatory Myopathies 16 Ag, Euroimmune, Lübeck, Germany). RESULTS: Of the 173 patients of JIIM in our cohort, assay for MSA/MAA was performed in 113 patients which included juvenile dermatomyositis (n=89), clinically amyopathic dermatomyositis (n=8), overlap myositis (n=13), and juvenile polymyositis (n=3). Autoantibody positivity was seen in 72.5% (82/113; MSA =70, MAA=12) of the children, with anti-NXP2 (n=24) being the most common followed by anti-MDA5 (n=14), anti-TIF-1γ (n=12), anti-Mi 2 (n=9) in that order. Patients with NXP2 positivity were younger at onset [3.15 years; (1.2-11.88 years) p=0.015], had severe muscle weakness at onset (p=0.04) and persistent calcinosis (p=0.004) in follow-up. Patients with anti-TIF1γ antibody were observed to have persistent skin lesions (p <0.001) during follow-up. Incidence of arthritis (p=0.001), inverse Gottron papules (p=0.003), skin ulceration (p=0.065), oral ulcers (p=0.012), and ILD (p<0.001) were high in anti-MDA5-JDM. CONCLUSION: Anti-NXP2 antibody is the most common MSA noted in our North Indian cohort of JIIM. The findings emphasize the importance of region-specific data in understanding disease variability and guiding management.
引用
- Vignesh P, Basu S, Nadig PL, et al. Spectrum of clinical phenotypes associated with myositis-specific and myositis-associated antibodies in juvenile idiopathic inflammatory myositis: Our experience from North India. Semin Arthritis Rheum. 2026. PMID: 41887030. doi:10.1016/j.semarthrit.2026.152972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。